Zhejiang Medicine Co., Ltd. (SHA:600216)
China
· Delayed Price · Currency is CNY 13.39
-0.27 (-1.98%)
Apr 28, 2025, 3:00 PM CST
Zhejiang Medicine Revenue
Zhejiang Medicine had revenue of 2.26B CNY in the quarter ending March 31, 2025, with 0.28% growth. This brings the company's revenue in the last twelve months to 9.38B, up 16.75% year-over-year. In the year 2024, Zhejiang Medicine had annual revenue of 9.38B with 20.29% growth.
Revenue (ttm)
9.38B
Revenue Growth
+16.75%
P/S Ratio
1.40
Revenue / Employee
1.51M
Employees
6,227
Market Cap
13.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.38B | 1.58B | 20.29% |
| Dec 31, 2023 | 7.79B | -321.66M | -3.96% |
| Dec 31, 2022 | 8.12B | -1.01B | -11.10% |
| Dec 31, 2021 | 9.13B | 1.80B | 24.60% |
| Dec 31, 2020 | 7.33B | 283.01M | 4.02% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |